Skip to main content
OpenTrials
Completed

NCT Number: NCT02512354

Contribution of High-throughput Exome Sequencing in the Diagnosis of the Cause Fetal Polymalformation Syndromes

This research concerns the contribution of a new examination, high-throughput exome sequencing, in the diagnosis of the cause of polymalformative fetal syndromes. With currently available examinations, the causes of polyformative syndromes, which correspond to the association of several congenital malformations with varying degrees of severity in different organs, remain unknown in a large number of cases.

High-throughput exome sequencing (HTES) is a diagnostic tool that allows the simultaneous analysis of all of the coding parts of DNA. This examination has already shown its superior diagnostic capability in every post-natal diagnostic context, in particulier in infants with malformations associated or not with intellectual deficiency. Its contribution has not yet been studied in a large number of fetuses with polymalformations. To investigate the usefulness of HTES, we propose to carry out the examination in 100 fetuses with polymalformations, as well as the usual examinations including chromosomal microarray analysis and possibly the study of specific genes that may explain these malformations. A blood sample will be taken from both parents to allow interpretation of the results.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Clermont-Ferrand, Clermont-Ferrand, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fetus with at least 2 malformations, with no diagnosis (or several low-certainty diagnostic hypotheses, which require several molecular examinations) after fetopathological and radiological examinations
  • Written consent from both parents
  • Possibility to obtain samples from both parents

Exclusion criteria

  • Refusal of parents to take part in the study
  • Parents without National Health Insurance cover
  • Parents under guardianship or in custody
  • Impossibility to obtain samples from both parents
  • Diagnostic hypothesis considered highly probable for which a molecular test cheaper that HTES is available

Treatment and study plan

Sample of a fragment of fetal tissue

Other

Parent's blood samples

Other

Primary outcomes

  1. Number of additional diagnoses made thanks to HTES compared with the usual examinations

    Time frame: baseline

  2. Number of diagnoses not made by HTES compared with usual examinations

    Time frame: baseline

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Official study title

Contribution of High-throughput Exome Sequencing in Fetopathology

Acronym: FOETEX

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Jul 30, 2015
Registry last updated
Feb 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.